SCHEMBL3641111

SCHEMBL3641111

CN(Cc1cc(C(F)(F)F)cc(C(F)(F)F)c1)C1CC(C(=O)N2CCN(c3ccccc3F)CC2)N(Cc2ccccc2)C1

nearest known ligand 0.44

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TACR3 P29371 1/20 0.44
KDM4E B2RXH2 8/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
TP53 P04637 1/20 0.42
ALDH1A1 P00352 4/20 0.41
TSHR P16473 2/20 0.41
ALOX15 P16050 2/20 0.41
GAA P10253 1/20 0.41
LMNA P02545 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
CHRM4 P08173 1/20 0.41
KMT2A Q03164 1/20 0.41
TACR1 P25103 3/20 0.40
POLB P06746 1/20 0.39
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2820035 1.00 TACR3 (0.44) TACR3KDM4ESMN1; SMN2TP53ALDH1A1
SCHEMBL2821138 0.94 CACNA1G (0.45) TACR3KDM4ESMN1; SMN2TP53ALDH1A1
SCHEMBL3637175 0.90 NPC1 (0.51) TACR3KDM4ESMN1; SMN2ALDH1A1TSHR
SCHEMBL2822151 0.90 NPC1 (0.51) TACR3KDM4ESMN1; SMN2ALDH1A1TSHR
SCHEMBL2819005 0.90 CHRM4 (0.43) TACR3CHRM4TACR1
SCHEMBL2817106 0.87 CHRM4 (0.47) KDM4ESMN1; SMN2ALDH1A1TSHRLMNA
SCHEMBL3638622 0.87 CHRM4 (0.47) KDM4ESMN1; SMN2ALDH1A1TSHRLMNA
SCHEMBL2822473 0.85 KMT2A (0.41) TACR3SMN1; SMN2ALDH1A1LMNACHRM4
SCHEMBL3641058 0.85 KMT2A (0.41) TACR3SMN1; SMN2ALDH1A1LMNACHRM4
SCHEMBL2819947 0.85 NPC1 (0.49) TACR3KDM4ESMN1; SMN2ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2155672-A1 PROLINAMIDE DERIVATIVES AS NK3 ANTAGONISTS F. Hoffmann-Roche AG (CH) 2010-02-24 EP disclosed
WO-2008148689-A1 PROLINAMIDE DERIVATIVES AS NK3 ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2008-12-11 WO disclosed